Niemann-Pick type C (NPC) diseases, caused by mutations in NPC1 or NPC2, are rare inherited disorders affecting cholesterol metabolism, and are characterised by progressive neurodegeneration and premature death. In some affected individuals, haematological defects such as thrombocytopenia (low platelet counts) and anaemia are also observed. Louwette et al. now characterise platelet abnormalities in three unrelated patients carrying NPC1 mutations, and in NPC1-depleted zebrafish embryos. In patients, platelets were present in normal numbers but showed functional impairments. Patients’ haematopoietic stem cells were defective in differentiation into megakaryocytes (platelet precursors), although red blood cells differentiated normally. Zebrafish embryos depleted for NPC1 showed abnormal numbers of thrombocytes and red blood cells, suggesting that the entire myeloid lineage was affected. How defects in lipid metabolism caused by NPC1 mutations lead to defects specifically in the myeloid lineage remains an open question.
Niemann-Pick disease and platelet dysfunction
- Split-screen
- Views Icon Views
- PDF LinkPDF
-
Article Versions Icon
Versions
- Version of Record 01 November 2012
- Share Icon Share
-
Tools Icon
Tools
- Search Site
Niemann-Pick disease and platelet dysfunction. Dis Model Mech 1 November 2012; 5 (6): 708. doi:
Download citation file:
Advertisement
Cited by
Virtual Meeting - Developmental Disorders: From Mechanism to Treatment
A collaboration between the Development and Disease Models & Mechanisms journal teams, this virtual Meeting will unite developmental biologists, human geneticists and clinical researchers to focus on building bridges from bench to clinic. Register your interest and find out more.
High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition
Vitamin B1 is shown to prevent nutrition-induced fatty liver in our current Editor’s choice by Hay Davir and his colleagues, when they use sheep as a large-animal model for studying the disease.
Find out more in an interview with the paper's first authors, Mugagga Kalyesubula and Ramgopal Mopuri.
Upcoming grant deadlines
Grants awarded by The Company of Biologists help scientists travel, attend events and host sustainable activities. Make a note of the upcoming application deadlines and find out more about the grants on offer:
DMM Conference Travel Grants
17 May 2021
Sustainable Conferencing Grants
17 May 2021
Travelling Fellowships
31 May 2021
Scientific Meeting Grants
4 June 2021
Call for papers - The RAS Pathway: Diseases, Therapeutics and Beyond
Our upcoming special issue is welcoming submissions until 3 May 2021. Guest-edited by Donita Brady (Perelman School of Medicine at the University of Pennsylvania, USA) and Arvin Dar (Icahn School of Medicine at Mount Sinai, USA), the issue will focus on targeting the RAS pathway.
Other journals from
The Company of Biologists